Topics

B cell count tells how certain cancers will respond to immunotherapy

16:30 EST 15 Jan 2020 | News-Medical.net

Some melanomas, sarcomas and renal cell carcinomas, but not all, have been found to respond dramatically to new drugs called immune checkpoint blockers, which exploit the body’s known capability to mount an immune response against the foreign antigen-bearing tumor cells.

Original Article: B cell count tells how certain cancers will respond to immunotherapy

NEXT ARTICLE

More From BioPortfolio on "B cell count tells how certain cancers will respond to immunotherapy"

Quick Search

Relevant Topic

Renal disease
Chronic kidney disease (CKD), also known as chronic renal disease, is a progressive loss in renal function over a period of months or years. The symptoms of worsening kidney function are non-specific, and might include feeling generally unwell and experi...